{
    "nct_id": "NCT06088043",
    "official_title": "A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis",
    "inclusion_criteria": "1. Plaque psoriasis for at least 6 months.\n2. Moderate to severe disease.\n3. Candidate for phototherapy or systemic therapy.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Other forms of psoriasis.\n2. History of recent infection.\n3. Prior exposure to TAK-279 or active comparator.\n\nOther protocol defined inclusion/exclusion criteria apply.",
    "miscellaneous_criteria": ""
}